Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Articles by Bankier, B. Articles by Januzzi, J. L. PubMed Citation Articles by Bankier, B. Articles by Januzzi, J. L. Depression Syndromes Secondary to General Medical Disorders

Association Between Anxiety and C-Reactive Protein Levels in Stable Coronary Heart Disease Patients

Received December 15, 2007; revised April 9, 2008; accepted April 9, 2008. From the Department of Psychiatry, and Division of Cardiology, Massachusetts General Hospital; and the Department of Psychiatry and Psychotherapy, Medical University Vienna, Austria. Send correspondence and reprint requests to Bettina Bankier, M.D., Sc.M., Department of Psychiatry and Psychotherapy, Medical University Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria. e-mail: bettina.bankier{at}meduniwien.ac.at
© 2009 The Academy of Psychosomatic Medicine

BACKGROUND: Anxiety is highly prevalent among patients with stable coronary heart disease (CHD). However, the biologic effects that may connect these two seemingly unrelated disorders is not well understood. OBJECTIVE: This study aimed for a comprehensive evaluation of anxiety in stable CHD patients, in addition to cardiac biomarkers such as C-reactive protein (CRP), troponin T, and amino-terminal pro-B-type brain natriuretic peptide. METHOD: The study included 43 CHD patients with anxiety disorder and 42 CHD patients without psychiatric disorder given the Structured Clinical Interview for DSM–IV. RESULTS: Regression analyses showed an association between anxiety (anxiety disorder, not otherwise specified) and CRP levels, despite model adjustment for various related demographic and clinical variables. Anxiety was associated with CRP levels. CONCLUSION: There are significant associations between anxiety and CHD risk, with a potential biologic link between anxiety and elevations in a biomarker with powerful prognostic risk, namely CRP. It is not clear whether this association is directly causal or relates to other medical processes among patients with heightened anxiety. The findings suggest that the current focus on depressive disorders with respect to biomarkers and CHD outcomes should be broadened to include anxiety disorders, as well.

Get information about faster international access.

Privacy Policy

Copyright © 2009 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us